Abdul Mullick

Abdul Mullick

Director Ejecutivo en KYOWA KIRIN CO., LTD. .
Health Technology
Consumer Services
Commercial Services

Perfil

Abdul Mullick is President, CEO, COO & Representative Director at Kyowa Kirin Co., Ltd. since 2026 and Director at Orchard Therapeutics Plc since 2024.
Former roles include President & Chief Executive Officer at Kyowa Kirin International Plc from 2018 to 2023, Director at Mereo BioPharma Group Plc in 2022, Head-Global Strategic Marketing at Vifor Pharma Management AG from 2014 to 2018, Senior Director-European Business Unit at Endocrine Pharmaceuticals Ltd., Senior Director-Global Brand & Diabetes at Novartis Pharma AG, Vice President, GM-Endocrinology & Cardiology at Genzyme Corp.
Education includes a doctorate from the University of Bristol.

Cargos activos de Abdul Mullick

EmpresasCargoInicio
ORCHARD THERAPEUTICS PLC Director/Miembro de la Junta 24/01/2024
KYOWA KIRIN CO., LTD. Director Ejecutivo 01/03/2026

Antiguos cargos conocidos de Abdul Mullick.

EmpresasCargoFin
Director Ejecutivo 01/01/2023
MEREO BIOPHARMA GROUP PLC Director/Miembro de la Junta 10/11/2022
Corporate Officer/Principal 01/04/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Abdul Mullick.

Formación de Abdul Mullick.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

60

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology